Thornburg Investment Management Inc Haemonetics Corp Transaction History

Thornburg Investment Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$49.27 - $66.08 $10.6 Million - $14.2 Million	-214,973 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$43.77 - $63.22 $126,976 - $183,401	-2,901 Reduced 1.33%	214,973 $13.6 Million
Q4 2021 Feb 10, 2022	SELL	$49.55 - $74.59 $1.35 Million - $2.03 Million	-27,269 Reduced 11.12%	217,874 $11.6 Million
Q3 2021 Nov 10, 2021	SELL	$57.6 - $70.59 $82,483 - $101,084	-1,432 Reduced 0.58%	245,143 $17.3 Million
Q2 2021 Aug 11, 2021	BUY	$51.81 - $118.56 $3.96 Million - $9.06 Million	76,422 Added 44.91%	246,575 $16.4 Million
Q1 2021 May 14, 2021	SELL	$111.01 - $139.48 $12.7 Million - $15.9 Million	-113,994 Reduced 40.12%	170,153 $18.9 Million
Q4 2020 Feb 09, 2021	BUY	$88.75 - $119.95 $6.33 Million - $8.56 Million	71,355 Added 33.53%	284,147 $33.7 Million
Q3 2020 Nov 05, 2020	BUY	$75.65 - $93.58 $16.1 Million - $19.9 Million	212,792 New	212,792 $18.6 Million

337

55.2M

383K

45.1K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.1B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Thornburg Investment Management Inc with notifications on news.